Investor profile
Novalis Biotech has backed 3 European tech companies across 4 funding rounds between 2022 and 2026, joining rounds totalling €23M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Enzyre | Netherlands | 1 | €12M |
| Altavo | Germany | 2 | €8.0M |
| Alithea Genomics | Switzerland | 1 | €3.3M |
| €3.0M |
| 2026-01 |
